Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 16 2018 - 7:28PM
Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS) today
announced that the Compensation Committee of the Company’s Board of
Directors granted Chhaya Shah, in connection with her appointment
as the Company’s Senior Vice President, Technical Operations, an
option to purchase 60,000 shares of the Company’s common stock with
a per share exercise price of $28.74, the closing trading price of
the Company’s common stock on the NASDAQ Global Market on the grant
date of July 16, 2018. The stock option vests 25% on the
first anniversary of the grant date, with the remaining 75% to vest
in monthly installments over the three years thereafter, subject to
continued service with the Company through the applicable vesting
dates, and has a ten-year term. The stock option was granted
as an inducement material to Ms. Shah entering into employment with
the Company in accordance with NASDAQ Listing Rule 5635(c)(4).
About Radius
Radius is a science-driven fully integrated biopharmaceutical
company that is committed to developing and commercializing
innovative endocrine therapeutics in the areas of osteoporosis and
oncology. For more information, please visit
www.radiuspharm.com.
Investor & Media Relations Contact:
Elhan Webb, CFAEmail: ewebb@radiuspharm.com Phone:
617-551-4011
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Apr 2023 to Apr 2024